Journal Information
Vol. 6. Issue 6.
Pages 299-302 (November - December 2010)
Share
Share
Download PDF
More article options
Vol. 6. Issue 6.
Pages 299-302 (November - December 2010)
Full text access
Frequency of systemic manifestations in patients with primary Sjögren's syndrome in Argentina
Frecuencia de manifestaciones sistémicas en pacientes con síndrome de Sjögren primario en Argentina
Visits
4914
Federico Zazzettia,
Corresponding author
reumatologia@hbritanico.com.ar

Corresponding author.
, Mariano Adolfo Riveroa, Damián Elvio Duartes Noéa, Alberto Gallachera, Amalia Schielb, Marina Claudia Khouryc, Hugo Armando Labordea, Juan Carlos Barreiraa
a Servicio de Reumatología, Buenos Aires, Argentina
b Sección Laboratorio de Inmunología, Buenos Aires, Argentina
c Departamento de Estadística, Hospital Británico de Buenos Aires, Buenos Aires, Argentina
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics
Abstract

Twenty to 71% of patients with Sjögren's syndrome (SS) will develop systemic manifestations.

Objetive

To characterize the clinical-serological presentation and the frequency of systemic manifestations in patients with primary SS.

Methods

Retrospective study including patients with SS visited in “Hospital Británico de Buenos Aires” during the period from January 2000 to August 2008.

Results

Forty-one patients fulfilled the 2002 American-European classification criteria for SS. All patients were women. Mean age at enrollment was 57,85±12,42 years (range 26–79). Mean duration of the disease was 9,28 years (range 0,08–24). Thirty-three (80.49%) developed systemic manifestations. The most frequent were arthritis, cutaneous vasculitis and polyneuropathy. This group featured more frequently ANA titles ≥1/640 and hypocomplementemia; although no statistical significance was found. The frequency of systemic manifestations found was greater than reported in the literature.

Conclusions

A multidisciplinary approach focusing also on systemic manifestations should be the new standard for management of SS.

Keywords:
Sjögren's Syndrome
Autoimmunity
Connective Tissue Diseases
Xerostomia
Resumen

Del 20–71% de los pacientes con síndrome de Sjögren (SS) desarrolla manifestaciones sistémicas.

Objetivos

El objetivo fue evaluar las características clinicoserológicas y frecuencia de manifestaciones sistémicas en pacientes con SS primario.

Material y métodos

Material y métodos: Estudio retrospectivo con revisión de historias clínicas de pacientes con Sd de Sjögren primario visitados en el Hospital Británico de Buenos Aires en el período desde Enero de 2000 a Agosto de 2008.

Resultados

Se incluyeron 41 pacientes que cumplian criterios de clasificacion Europeoamericanos 2002 para SS, todos de sexo femenino. La edad media fue 57,85±12,42 anos (rango 26–79). El tiempo de evolucion fue de 9,28 anos (rango 0,08–24). Treinta y tres (80,49%) presentaron manifestaciones sistemicas. Las mas frecuentes fueron artritis, vasculitis cutanea y polineuropatia. Este grupo presento mas frecuentemente titulos de AAN ≥1/640 e hipocomplementemia; aunque no estadisticamente significativas. La frecuencia de manifestaciones sistemicas halladas fue mayor a la reportada en otras series.

Conclusiones

Un abordaje multidisciplinario enfocado en las manifestaciones sistémicas debería ser el nuevo estándar para el manejo del SS.

Palabras clave:
Síndrome de Sjögren
Autoinmunidad
Enfermedades del tejido conectivo
Xerostomía
Full text is only aviable in PDF
References
[1.]
A. Hansen, P.E. Lipsky, T. Dorner.
Immunopathogenesis of primary Sjögren's syndrome: implications for disease management and therapy (review).
Curr Opin Rheumatol, 17 (2005), pp. 558-565
[2.]
R. Gerli, C. Muscat, M. Giansanti, M.G. Danieli, M. Sciuto, A. Gabrielli, et al.
Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder.
Br J Rheumatol, 36 (1997), pp. 969-975
[3.]
M. Garcia-Carrasco, M. Ramos-Casals, J. Rosas, L. Pallarés, J. Calvo-Alen, R. Cervera, et al.
Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients.
Medicine (Baltimore), 81 (2002), pp. 270-280
[4.]
R.I. Fox.
Sjögren's syndrome (review).
[5.]
E. Theander, S.I. Andersson, R. Manthorpe, L.H. Jacobsson.
Proposed core set of outcome measures in patients with primary Sjögren's syndrome: 5 year followup.
J Rheumatol, 32 (2005), pp. 109-116
[6.]
M. Ramos-Casals, A.G. Tzioufas, J. Font.
Primary Sjögren's syndrome: new clinical and therapeutic concepts (review).
Ann Rheum Dis, 64 (2005), pp. 347-354
[7.]
N. Talal.
What is Sjögren's syndrome and why is it important?.
J Rheumatol, 27 (2000), pp. 1-3
[8.]
N.A. Pavlidis, J. Karsh, H.M. Moutsopoulos.
The clinical picture of primary Sjögren's syndrome: a retrospective study.
J Rheumatol, 9 (1982), pp. 685-690
[9.]
C. Vitali, S. Bombardieri, R. Jonsson, H.M. Moutsopoulos, E.L. Alexander, S.E. Carsons, European Study Group on classification criteria for Sjögren's syndrome, et al.
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.
Ann Rheum Dis, 61 (2002), pp. 554-558
[10.]
D.I. Mitsias, E.K. Kapsogeorgou, H.M. Moutsopoulos.
Sjögren's syndrome: why autoimmune epithelitis?.
[11.]
J.P. Ioannidis, V.A. Vassiliou, H.M. Moutsopoulos.
Long term risk of mortality and lymphoproliferative diseases and predictive classification of primary Sjögren's syndrome.
Arthritis Rheum, 46 (2002), pp. 741-747
[12.]
E. Theander, L.T.H. Jacobsson.
Relationship of Sjögren's syndrome to other connective tissue and autoimmune disorders.
Rheum Dis Clin N Am, 34 (2008), pp. 935-947
[13.]
M. Ramos-Casals, R. Solans, J. Rosas, M.T. Camps, A. Gil, J. Del Pino-Montes, et al.
Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients.
Medicine (Baltimore), 87 (2008), pp. 210-219
[14.]
K. Asmussen, V. Anderson, G. Bendixen, M. Schiødt, P. Oxholm.
A new model for classification of disease manifestations in primary Sjögren's syndrome: evaluation in a retrospective long-term study.
J Intern Med, 239 (1996), pp. 475-482
[15.]
J.M. Anaya, P.A. Correa, R.D. Mantilla.
Síndrome de Sjogren primario. Manifestaciones clínicas e inmunogenéticas.
Acta Med Colomb, 24 (1999), pp. 127-136
[16.]
F. Shah, R.P. Rapini, F.C. Arnett, N.B. Warner, C.A. Smith.
Association of labial salivary gland histopathology with clinical and serologic features of connective tissue diseases.
Arthritis Rheum, 33 (1990), pp. 1682-1687
Copyright © 2010. Sociedad Española de Reumatología and Colegio Mexicano de Reumatología
Idiomas
Reumatología Clínica (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?